|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS175744: HP:0001231 Abnormality of the fingernails
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS135594: mean cell hemoglobin concentration QTL 1 (Chcmq1, Published QTL Chr 2)
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS135564: cytokine deficiency colitis susceptibility 3 (Cdcs3, Published QTL Chr 2)
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS136114: body length 1 (Lgth1, Published QTL Chr 2)
|
|
GS178461: GO:0009987 cellular process
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS174979: HP:0011061 Abnormality of dental structure
|
|
GS190626: GO:0042254 ribosome biogenesis
|
|
GS836: Differential expression in Sey Pax6 mutants and controls. Additive effect of mutation, linear increase in both mutants and Wild-types.
|
|
GS172294: HP:0001510 Growth delay
|
|
GS174372: HP:0002024 Malabsorption
|
|
GS173392: HP:0003330 Abnormal bone structure
|
|
GS129192: type 2 diabetes mellitus 2 in SMXA RI mice (T2dm2sa Published QTL Chr 2)
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS171784: HP:0001399 Hepatic failure
|
|
GS193268: GO:0005575 cellular_component
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS174644: HP:0000953 Hyperpigmentation of the skin
|
|
GS1229: Differential gene expression among both the Heroin and Cocaine Abusers
|
|
GS171596: HP:0000164 Abnormality of the teeth
|
|
GS176779: HP:0010450 Esophageal stenosis
|
|
GS174840: HP:0011358 Generalized hypopigmentation of hair
|
|
GS175538: HP:0011276 Vascular skin abnormality
|
|
GS199273: GO:0043233 organelle lumen
|
|
GS171902: HP:0010987 Abnormality of cellular immune system
|
|
GS172701: HP:0002650 Scoliosis
|
|
GS174818: HP:0007495 Prematurely aged appearance
|
|
GS176718: HP:0000078 Abnormality of the genital system
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS172293: HP:0001511 Intrauterine growth retardation
|
|
GS173014: HP:0010936 Abnormality of the lower urinary tract
|
|
GS176142: HP:0001034 Hypermelanotic macule
|
|
GS170783: HP:0010974 Abnormality of myeloid leukocytes
|
|
GS174484: HP:0000521 Abnormality of tear glands or tear production
|
|
GS182313: GO:0044085 cellular component biogenesis
|
|
GS175332: HP:0000032 Abnormality of male external genitalia
|
|
GS199228: GO:0015030 Cajal body
|
|
GS172471: HP:0001744 Splenomegaly
|
|
GS174854: HP:0001410 Decreased liver function
|
|
GS135237: activity response to ethanol 4 (Actre4, Published QTL Chr 2)
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS192017: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS172887: HP:0100533 Inflammatory abnormality of the eye
|
|
GS175594: HP:0011014 Abnormal glucose homeostasis
|
|
GS136403: organ weight QTL 3 (Orgwq3, Published QTL Chr 2)
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS175670: HP:0007364 Aplasia/Hypoplasia of the cerebrum
|
|
GS191106: GO:0044464 cell part
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS173290: HP:0011354 Generalized abnormality of skin
|
|
GS176711: HP:0100585 Teleangiectasia of the skin
|
|
GS174579: HP:0002031 Abnormality of the esophagus
|
|
GS135858: femur breaking strength 1 (Fembrs1, Published QTL Chr 2)
|
|
GS136105: lymph node cytotoxic T lymphocyte percentage 1 (Lctlp1, Published QTL Chr 2)
|
|
GS186227: GO:0090304 nucleic acid metabolic process
|
|
GS201251: GO:0044424 intracellular part
|
|
GS135670: circadian period of locomotor activity 7 (Cplaq7, Published QTL Chr 2)
|
|
GS136797: total body bone mineral density 2 (Tbbmd2, Published QTL Chr 2)
|
|
GS172031: HP:0000364 Hearing abnormality
|
|
GS178359: GO:0071840 cellular component organization or biogenesis
|
|
GS203908: GO:0016070 RNA metabolic process
|
|
GS174380: HP:0010624 Aplastic/hypoplastic toenails
|
|
GS172416: HP:0002242 Abnormality of the intestine
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS135418: bitterness sensitivity 1 (Bits1, Published QTL Chr 2)
|
|
GS180942: GO:0006396 RNA processing
|
|
GS136639: salmonella enteritidis susceptibility 7 (Ses7, Published QTL Chr 2)
|
|
GS135708: diabetes susceptibility QTL 5 (Dbsq5, Published QTL Chr 2)
|
|
GS175372: HP:0011481 Abnormality of the lacrimal duct
|
|
GS176840: HP:0001911 Abnormality of granulocytes
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS135554: CD8 memory T cell subset 3 (Cd8mts3, Published QTL Chr 2)
|
|
GS136735: segregation of mitochondrial DNA QTL 2 (Smdq2, Published QTL Chr 2)
|
|
GS193935: GO:0006364 rRNA processing
|
|
GS135219: aberrant activation of B cell proliferation (Aabpr, Published QTL Chr 2)
|
|
GS174291: HP:0002575 Tracheoesophageal fistula
|
|
GS175805: HP:0003271 Visceromegaly
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS171126: HP:0000022 Abnormality of male internal genitalia
|
|
GS174338: HP:0002719 Recurrent infections
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS175907: HP:0004349 Reduced bone mineral density
|
|
GS209551: GO:0031981 nuclear lumen
|
|
GS173377: HP:0002209 Sparse scalp hair
|
|
GS136115: body length 2 (Lgth2, Published QTL Chr 2)
|
|
GS176100: HP:0000925 Abnormality of the vertebral column
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS173838: HP:0002778 Abnormality of the trachea
|
|
GS173892: HP:0005528 Bone marrow hypocellularity
|
|
GS174378: HP:0000518 Cataract
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS197472: GO:0044451 nucleoplasm part
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS205822: GO:0001522 pseudouridine synthesis
|
|
GS176186: HP:0000079 Abnormality of the urinary system
|
|
GS171277: HP:0100547 Abnormality of the forebrain
|
|
GS84133: activity response to ethanol (Published QTL, Chr 2)
|
|
GS175456: HP:0100037 Abnormality of the scalp hair
|
|
GS176420: HP:0100671 Abnormal trabecular bone morphology
|
|
GS202843: GO:0016604 nuclear body
|
|
GS173273: HP:0002216 Premature graying of hair
|
|
GS175909: HP:0004348 Abnormality of bone mineral density
|
|
GS171067: HP:0002664 Neoplasm
|
|
GS172127: HP:0000632 Lacrimation abnormality
|
|
GS173355: HP:0002205 Recurrent respiratory infections
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS173155: HP:0005561 Abnormality of bone marrow cell morphology
|
|
GS135685: C. trachomatis resistance QTL 1 (Ctrq1, Published QTL Chr 2)
|
|
GS136950: weight gain in high growth mice 5 (Wg5, Published QTL Chr 2)
|
|
GS171789: HP:0001392 Abnormality of the liver
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS176632: HP:0001903 Anemia
|
|
GS176765: HP:0001009 Telangiectasia
|
|
GS175220: HP:0009887 Abnormality of hair pigmentation
|
|
GS136377: obesity QTL 3 (Obq3, Published QTL Chr 2)
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS173087: HP:0000499 Abnormality of the eyelashes
|
|
GS136872: T cell ratio modifier QTL 2 (Trmq2, Published QTL Chr 2)
|
|
GS170989: HP:0010766 Ectopic calcification
|
|
GS171171: HP:0005607 Abnormality of the tracheobronchial system
|
|
GS172030: HP:0000365 Hearing impairment
|
|
GS172185: HP:0002977 Aplasia/Hypoplasia involving the central nervous system
|
|
GS175602: HP:0002087 Abnormality of the upper respiratory tract
|
|
GS175546: HP:0010885 Aseptic necrosis
|
|
GS176640: HP:0011357 Abnormality of hair density
|
|
GS200149: GO:0022613 ribonucleoprotein complex biogenesis
|
|
GS171226: HP:0000812 Abnormal internal genitalia
|
|
GS173024: HP:0000811 Abnormal external genitalia
|
|
GS196553: GO:0005730 nucleolus
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS203594: GO:0043226 organelle
|
|
GS205364: GO:0010467 gene expression
|
|
GS174756: HP:0011947 Respiratory tract infection
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS207521: GO:0042254 ribosome biogenesis
|
|
GS175530: HP:0000002 Abnormality of body height
|
|
GS172655: HP:0001792 Small nail
|
|
GS193365: GO:0034470 ncRNA processing
|
|
GS86977: Table S1: All transcripts significantly different in abundance between the majority of heroin subjects and their matched controls [DRG]
provisional
|
|
GS175523: HP:0000008 Abnormality of female internal genitalia
|
|
GS177035: HP:0001928 Abnormality of coagulation
|
|
GS136090: lean body mass 2 (Lbm2, Published QTL Chr 2)
|
|
GS182492: GO:0034660 ncRNA metabolic process
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS186744: GO:0043226 organelle
|
|
GS178358: GO:0071843 cellular component biogenesis at cellular level
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS135694: directional asymmetry QTL 18 (Daq18, Published QTL Chr 2)
|
|
GS174189: HP:0001597 Abnormality of the nail
|
|
GS171115: HP:0001053 Hypopigmented skin patches
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS174179: HP:0002514 Cerebral calcification
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS135795: ethanol induced low dose activation 3 (Elda3, Published QTL Chr 2)
|
|
GS176672: HP:0000980 Pallor
|
|
GS173387: HP:0002757 Recurrent fractures
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS194087: GO:0003674 molecular_function
|
|
GS173554: HP:0005374 Cellular immunodeficiency
|
|
GS206092: GO:0009451 RNA modification
|
|
GS135918: graft-versus host disease 3 (Gvhd3, Published QTL Chr 2)
|
|
GS171602: HP:0001965 Abnormality of the scalp
|
|
GS174030: HP:0009926 Increased lacrimation
|
|
GS175692: HP:0200042 Skin ulcer
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS173090: HP:0004377 Hematological neoplasm
|
|
GS84131: ethanol consumption (Published QTL, Chr 2)
|
|
GS177356: GO:0003674 molecular_function
|
|
GS195111: GO:0071843 cellular component biogenesis at cellular level
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS199289: GO:0034660 ncRNA metabolic process
|
|
GS172624: HP:0000653 Sparse eyelashes
|
|
GS173533: HP:0001876 Pancytopenia
|
|
GS171645: HP:0011843 Abnormality of skeletal physiology
|
|
GS176642: HP:0011355 Localized skin lesion
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS172839: HP:0010674 Abnormality of the curvature of the vertebral column
|
|
GS175068: HP:0000971 Abnormality of the sweat gland
|
|
GS175119: HP:0001881 Abnormality of leukocytes
|
|
GS173019: HP:0000819 Diabetes mellitus
|
|
GS173540: HP:0002115 Sparse or absent hair
|
|
GS175084: HP:0008384 Aplastic/hypoplastic fingernail
|
|
GS176790: HP:0008070 Sparse hair
|
|
GS194336: GO:0043412 macromolecule modification
|
|
GS195199: GO:0005634 nucleus
|
|
GS180166: GO:0008152 metabolic process
|
|
GS176806: HP:0003812 Phenotypic variability
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS136472: periosteal circumference and femur length 2 (Pcfm2, Published QTL Chr 2)
|
|
GS175500: HP:0000517 Abnormality of the lens
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS175083: HP:0008386 Aplasia/Hypoplasia of the nails
|
|
GS171336: HP:0001732 Abnormality of the pancreas
|
|
GS207972: GO:0030529 ribonucleoprotein complex
|
|
GS136445: peripheral blood stem cell response to granulocyte colony stimulating factor 1 (Pbrgcsf1, Published QTL Chr 2)
|
|
GS173534: HP:0001877 Abnormality of erythrocytes
|
|
GS136011: heart rate quantitative locus 1 (Hrq1, Published QTL Chr 2)
|
|
GS203369: GO:0005654 nucleoplasm
|
|
GS171788: HP:0001394 Cirrhosis
|
|
GS128575: Ethanol induced LORR Chr# 2
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS172040: HP:0000962 Hyperkeratosis
|
|
GS170791: HP:0010978 Abnormality of immune system physiology
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS136600: serum alkaline phosphatase activity 1 (Salpa1, Published QTL Chr 2)
|
|
GS176560: HP:0001010 Hypopigmentation of the skin
|
|
GS199112: GO:0044085 cellular component biogenesis
|
|
GS205543: GO:0070013 intracellular organelle lumen
|
|
GS129195: Tmc1 modifier 1 (Tmc1m1 Published QTL Chr 2)
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS176573: HP:0008065 Aplasia/Hypoplasia of the skin
|
|
GS172470: HP:0001743 Abnormality of the spleen
|
|
GS175958: HP:0000795 Abnormality of the urethra
|
|
GS171916: HP:0002665 Lymphoma
|
|
GS175098: HP:0000284 Abnormality of the ocular region
|
|
GS197734: GO:0006396 RNA processing
|
|
GS173296: HP:0011830 Abnormality of oral mucosa
|
|
GS173104: HP:0000670 Carious teeth
|
|
GS195214: GO:0009987 cellular process
|
|
GS129156: multigenic obesity QTL 5 (Mobq5 Published QTL Chr 2)
|
|
GS172692: HP:0002659 Increased susceptibility to fractures
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS176842: HP:0001915 Aplastic anemia
|
|
GS136364: obesity QTL 10 (Obq10, Published QTL Chr 2)
|
|
GS172415: HP:0002240 Hepatomegaly
|
|
GS201249: GO:0044428 nuclear part
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS183353: GO:0022613 ribonucleoprotein complex biogenesis
|
|
GS135855: femoral bone morphometry 4 (Fembm4, Published QTL Chr 2)
|
|
GS136160: leishmaniasis resistance 14 (Lmr14, Published QTL Chr 2)
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS174099: HP:0011793 Neoplasm by anatomical site
|
|
GS198263: GO:0005488 binding
|
|
GS135837: total fat pad mass QTL 1 (Fatmq1, Published QTL Chr 2)
|
|
GS171309: HP:0000252 Microcephaly
|
|
GS173535: HP:0001874 Abnormality of neutrophils
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS171305: HP:0012145 Abnormality of multiple cell lineages in the bone marrow
|
|
GS174948: HP:0100763 Abnormality of the lymphatic system
|
|
GS174236: HP:0000534 Abnormality of the eyebrow
|
|
GS175529: HP:0000001 All
|
|
GS175423: HP:0010461 Abnormality of the male genitalia
|
|
GS171446: HP:0000600 Abnormality of the pharynx
|
|
GS176419: HP:0100670 Rough bone trabeculation
|
|
GS175086: HP:0008388 Abnormality of the toenails
|
|
GS175064: HP:0000975 Hyperhidrosis
|
|
GS210307: GO:0034470 ncRNA processing
|
|
GS135892: failure of ureteric bud invasion 1 (Fubi1, Published QTL Chr 2)
|
|
GS184447: GO:0044424 intracellular part
|
|
GS129169: plasma plant sterol 2b (Plast2b Published QTL Chr 2)
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS175597: HP:0011013 Abnormality of carbohydrate metabolism/homeostasis
|
|
GS175796: HP:0002894 Neoplasm of the pancreas
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS135584: cholesterol absorption 1 (Chab1, Published QTL Chr 2)
|
|
GS173538: HP:0001873 Thrombocytopenia
|
|
GS174190: HP:0001596 Alopecia
|
|
GS172637: HP:0010460 Abnormality of the female genitalia
|
|
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS173872: HP:0011368 Epidermal thickening
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS180164: GO:0008150 biological_process
|
|
GS175333: HP:0000035 Abnormality of the testis
|
|
GS195911: GO:0005732 small nucleolar ribonucleoprotein complex
|
|
GS177212: GO:0006364 rRNA processing
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS171202: HP:0100627 Displacement of the external urethral meatus
|
|
GS171845: HP:0008066 Abnormal blistering of the skin
|
|
GS175191: HP:0002060 Abnormality of the cerebrum
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS136527: prion disease incubation time 1 (Prdt1, Published QTL Chr 2)
|
|
GS171448: HP:0000606 Abnormality of the periorbital region
|
|
GS188506: GO:0010467 gene expression
|
|
GS208012: GO:0044464 cell part
|
|
GS191064: GO:0030529 ribonucleoprotein complex
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS210212: GO:0005575 cellular_component
|
|
GS136595: rotarod performance 2 (Rrodp2, Published QTL Chr 2)
|
|
GS171660: HP:0000614 Abnormality of the nasolacrimal system
|
|
GS174081: HP:0004322 Short stature
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS173020: HP:0000818 Abnormality of the endocrine system
|
|
GS135235: activity response to ethanol 2 (Actre2, Published QTL Chr 2)
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS174785: HP:0002043 Esophageal stricture
|
|
GS136914: vertebral morphology and mechanical traits 2 (Vmmt2, Published QTL Chr 2)
|
|
GS136873: T cell ratio modifier QTL 3 (Trmq3, Published QTL Chr 2)
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS170823: HP:0002165 Pterygium formation (nails)
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS172403: HP:0011873 Abnormal platelet count
|
|
GS176771: HP:0001000 Abnormality of skin pigmentation
|
|
GS176759: HP:0000982 Palmoplantar keratoderma
|
|
GS136360: Neuroadapted Sindbis viral RNA level 1 (Nsv1, Published QTL Chr 2)
|
|
GS174385: HP:0002088 Abnormality of the lung
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS84132: ethanol induced locomotor activity (Published QTL, Chr 2)
|
|
GS173616: HP:0002745 Oral leukoplakia
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS136010: hemotopoietic response to early cytokines (Hrec, Published QTL Chr 2)
|
|
GS187047: GO:0016072 rRNA metabolic process
|
|
GS136055: IgA nephropathy QTL 1 (Ignpq1, Published QTL Chr 2)
|
|
GS182834: GO:0005623 cell
|
|
GS173083: HP:0000492 Abnormality of the eyelid
|
|
GS170889: HP:0006482 Abnormality of dental morphology
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS178448: GO:0005634 nucleus
|
|
GS175335: HP:0000036 Abnormality of the penis
|
|
GS199635: GO:0005622 intracellular
|
|
GS171461: HP:0011121 Abnormality of skin morphology
|
|
GS175118: HP:0000579 Nasolacrimal duct obstruction
|
|
GS196943: GO:0008152 metabolic process
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS173537: HP:0001872 Abnormality of thrombocytes
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS199634: GO:0005623 cell
|
|
GS203910: GO:0016072 rRNA metabolic process
|
|
GS173561: HP:0000691 Microdontia
|
|
GS172500: HP:0007400 Irregular hyperpigmentation
|
|
GS187045: GO:0016070 RNA metabolic process
|
|
GS201256: GO:0044422 organelle part
|
|
GS175814: HP:0011024 Abnormality of the gastrointestinal tract
|
|
GS135704: diabetes mRNA cluster 1 (Dbmc1, Published QTL Chr 2)
|
|
GS201431: GO:0005515 protein binding
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS170824: HP:0002164 Nail dysplasia
|
|
GS175928: HP:0000240 Abnormality of skull size
|
|
GS176540: HP:0002721 Immunodeficiency
|
|
GS176973: HP:0001072 Thickened skin
|
|
GS177055: HP:0005599 Hypopigmentation of hair
|